1200 Participants Needed

Mobile Text Messaging Support for Smoking Cessation

PC
VC
Overseen ByVivian Cortez, MS
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center at San Antonio
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial tests Quitxt, a mobile program that sends supportive texts and chat messages to help young Latino adults quit smoking. The study focuses on this group because they have high smoking rates and face significant health risks. Quitxt aims to boost users' confidence and skills to quit smoking through culturally relevant messages. Text messaging programs on mobile phones have shown some promise in helping people quit smoking.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on smoking cessation support through text messaging.

What data supports the effectiveness of the treatment Quitxt for smoking cessation?

Research shows that text messaging is an effective way to help people quit smoking. Studies have found that text-based programs, like Quitxt, can successfully support smoking cessation by providing timely advice and motivation.12345

Is mobile text messaging support for smoking cessation safe for humans?

The studies on mobile text messaging programs for smoking cessation, like Quitxt and Text2Quit, do not report any safety concerns. Participants generally found these programs helpful and engaging, suggesting they are safe to use.12678

How is the Quitxt treatment for smoking cessation unique?

Quitxt is unique because it uses mobile text messaging to provide interactive, automated support for quitting smoking, offering personalized advice and emergency help, which is different from traditional methods like nicotine patches or counseling.1291011

Research Team

PC

Patricia Chalela, DrPH

Principal Investigator

University of Texas Health Science Center San Antonio

Eligibility Criteria

This study is for Latino young adults aged 18-29 who smoke at least one cigarette a day, want to quit smoking, own a cell phone with text and internet capabilities, and can provide follow-up data. They should not be in another cessation program or planning to move from the study area during the trial.

Inclusion Criteria

Smoking at least one cigarette/day ≥3 days/week
Own a cell phone or smartphone
Able to send and receive text messages and access the Internet
See 6 more

Exclusion Criteria

Do not own a cell phone with text and Internet capabilities
I am not interested in quitting smoking.
I am unable to understand the consent information due to a condition.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Quitxt intervention or usual care for smoking cessation

6 months
Baseline and follow-up assessments at 1, 3, and 6 months

Follow-up

Participants are monitored for smoking cessation through self-reports and biochemical verification

6 months
Follow-up assessments at 1, 3, and 6 months

Treatment Details

Interventions

  • Quitxt
Trial Overview The Quitxt research study tests a mobile text messaging intervention designed to help young Latino adults stop smoking. Participants are randomly assigned to receive either interactive Quitxt messages or standard texts with cessation content plus referral to an existing state health service program.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Usual careExperimental Treatment1 Intervention
Abbreviated text messaging with smoking cessation-related content and referral to the Texas Department of State Health Services (TDSHS) cessation program Yes Quit (www.yesquit.org) available to smokers seeking help quitting. The abbreviated text messaging will include general information on smoking harms and benefits of cessation, and baseline data collection and follow-up assessments.
Group II: Quitxt bilingual text messaging and chatExperimental Treatment1 Intervention
Culturally and linguistically tailored, bilingual text messaging or chat mobile app. Our text messaging or chat intervention will include messaging options in which users can text or message a code when they are craving a cigarette or at risk of relapse and immediately receive text or social media messages to help them avoid smoking. The social media content also will include opportunities for users to repeatedly visit key content pages and receive immediate support when experiencing cravings, stress, bad mood, or when feeling at risk of smoking.

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center at San Antonio

Lead Sponsor

Trials
486
Recruited
92,500+

Cancer Prevention Research Institute of Texas

Collaborator

Trials
55
Recruited
98,900+

The University of Texas at San Antonio

Collaborator

Trials
24
Recruited
7,600+

Findings from Research

In a study involving 924 smokers using the QuitTxt program, most participants (68.9%) preferred the default messaging frequency of 4-8 texts per day, and the median duration of use was 27 days, indicating a generally positive reception of the program.
Despite some users not fully reporting their quit status, many still found QuitTxt helpful, suggesting that consistent reporting may not be crucial for the program's effectiveness in supporting smoking cessation.
How do smokers use a smoking cessation text messaging intervention?Balmford, J., Borland, R.[2018]
A study involving 102 young adult smokers found that a smartphone application (REQ-Mobile) was feasible for smoking cessation support, with 75% of users rating it as user-friendly.
However, the text messaging system (onQ) was more effective in promoting abstinence, with a significant number of users reporting higher rates of quitting compared to those using the app.
Randomized trial of a smartphone mobile application compared to text messaging to support smoking cessation.Buller, DB., Borland, R., Bettinghaus, EP., et al.[2022]
The Text2Quit program, which sends personalized text messages and emails to support smoking cessation, was well-received by university students, with 90.5% liking the program at 2 weeks and 82.3% at 4 weeks after enrollment.
Participants engaged actively with the program, averaging 11.8 responses to texts in the first 4 weeks, indicating that the interactive features, especially tracking cigarette use, were effective in maintaining user involvement.
Text2Quit: results from a pilot test of a personalized, interactive mobile health smoking cessation program.Abroms, LC., Ahuja, M., Kodl, Y., et al.[2022]

References

How do smokers use a smoking cessation text messaging intervention? [2018]
Randomized trial of a smartphone mobile application compared to text messaging to support smoking cessation. [2022]
Feasibility and Smokers' Evaluation of Self-Generated Text Messages to Promote Quitting. [2020]
Text2Connect: a health system approach to engage tobacco users in quitline cessation services via text messaging. [2023]
Large multi-centre pilot randomized controlled trial testing a low-cost, tailored, self-help smoking cessation text message intervention for pregnant smokers (MiQuit). [2022]
Text2Quit: results from a pilot test of a personalized, interactive mobile health smoking cessation program. [2022]
Analysing user-reported data for enhancement of SmokefreeTXT: a national text message smoking cessation intervention. [2018]
Feasibility of a text-based smoking cessation intervention in rural older adults. [2019]
Text messaging-based smoking cessation intervention: a narrative review. [2022]
[Continuous individual support of smoking cessation in socially deprived young adults via mobile phones--results of a pilot study]. [2017]
Pilot RCT results of stop my smoking USA: a text messaging-based smoking cessation program for young adults. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security